$173 Million is the total value of JNE Partners LLP's 13 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ATVI | ACTIVISION BLIZZARD INC | $45,214,000 | -4.5% | 608,200 | 0.0% | 26.16% | -15.4% | |
NSIT | INSIGHT ENTERPRISES INC | $18,377,000 | -4.5% | 223,000 | 0.0% | 10.63% | -15.4% | |
MSDAU | MSD ACQUISITION CORPunit 03/25/2026 | $14,865,000 | +0.4% | 1,500,000 | 0.0% | 8.60% | -11.0% | |
ORIAU | ORION BIOTECH OPPORTUNTES COunit 04/15/2025 | $14,775,000 | +0.1% | 1,500,000 | 0.0% | 8.55% | -11.3% | |
EOCWU | ELLIOTT OPPORTUNITY II CORPunit 99/99/9999 | $10,857,000 | +0.7% | 1,100,000 | 0.0% | 6.28% | -10.8% | |
NG | NOVAGOLD RES INC | $9,169,000 | -2.5% | 1,955,047 | 0.0% | 5.31% | -13.6% | |
BABA | ALIBABA GROUP HLDG LTDsponsored ads | $6,559,000 | -29.6% | 82,000 | 0.0% | 3.80% | -37.7% | |
BATRK | LIBERTY MEDIA CORP DEL | $5,555,000 | +14.6% | 202,000 | 0.0% | 3.22% | +1.5% | |
RKTAU | ROCKET INTERNET GRWT OPRT COunit 99/99/9999 | $4,251,000 | +1.0% | 430,234 | 0.0% | 2.46% | -10.5% | |
UHAL | AMERCO | $3,259,000 | +6.5% | 6,400 | 0.0% | 1.89% | -5.7% | |
KAHCU | KKR ACQUISITION HOLDING I COunit 99/99/9999 | $2,266,000 | -0.3% | 229,866 | 0.0% | 1.31% | -11.7% | |
W | WAYFAIR INCcl a | $2,207,000 | -25.3% | 67,800 | 0.0% | 1.28% | -33.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NOVAGOLD RES INC | 16 | Q3 2023 | 34.9% |
AMERCO | 11 | Q3 2022 | 40.0% |
ELLIOTT OPPORTUNITY II CORP | 9 | Q2 2023 | 19.8% |
COMCAST CORP NEW | 8 | Q1 2022 | 23.5% |
ORION BIOTECH OPPORTUNTES CO | 8 | Q1 2023 | 11.1% |
MSD ACQUISITION CORP | 8 | Q4 2022 | 11.1% |
LIBERTY MEDIA CORP DEL | 8 | Q2 2023 | 13.9% |
ROCKET INTERNET GRWT OPRT CO | 8 | Q4 2022 | 3.2% |
KKR ACQUISITION HOLDING I CO | 7 | Q3 2022 | 1.7% |
MICRON TECHNOLOGY INC | 5 | Q3 2023 | 56.9% |
View JNE Partners LLP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Prevail Therapeutics Inc. | January 29, 2021 | ? | ? |
View JNE Partners LLP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-15 |
View JNE Partners LLP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.